Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis

Pharmaceutical Research

Volumn 27, Issue 2, 2010, Pages 264-271

  Sun, Qinghua ^a,b,c   Silva, Eduardo A ^d   Wang, Aixia ^c   Fritton, James C ^e   Mooney, David J ^d   Schaffler, Mitchell B ^e   Grossman, Paul M ^f   Rajagopalan, Sanjay ^b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d HARVARD UNIVERSITY   (United States)

^e CITY UNIVERSITY OF NEW YORK   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Alginate; Angiogenesis; PDGF; Polymer; VEGF

Indexed keywords

ALGINIC ACID; GROWTH FACTOR; MICROSPHERE; POLYGLACTIN; POLYMER; VASCULOTROPIN 165;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LASER DOPPLER FLOWMETRY; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION; VASCULARIZATION;

ALGINATES; ANGIOGENESIS INHIBITORS; ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GLUCURONIC ACID; HEXURONIC ACIDS; HINDLIMB; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISCHEMIA; MALE; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; POLYESTERS; POLYMERS; RANDOM ALLOCATION;

EID: 77949270271     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-0014-0     Document Type: Article

References (26)

1. GD Yancopoulos S Davis NW Gale JS Rudge SJ Wiegand J Holash 2000 Vascular-specific growth factors and blood vessel formation Nature 407 242 248 10.1038/35025215 1:CAS:528:DC%2BD3cXmvVSlsrY%3D 11001067
2. M Hedman J Hartikainen M Syvanne J Stjernvall A Hedman A Kivela, et al. 2003 Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT) Circulation 107 2677 2683 10.1161/01.CIR.0000070540.80780.92 1:CAS:528:DC%2BD3sXjvFKjtbY%3D 12742981
3. TD Henry BH Annex GR McKendall MA Azrin JJ Lopez FJ Giordano, et al. 2003 The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis Circulation 107 1359 1365 10.1161/01.CIR.0000061911.47710.8A 1:CAS:528:DC%2BD3sXhslGjsbo%3D 12642354 (Pubitemid 36350732)
4. TP Richardson MC Peters AB Ennett DJ Mooney 2001 Polymeric system for dual growth factor delivery Nat Biotechnol 19 1029 1034 10.1038/nbt1101-1029 1:CAS:528:DC%2BD3MXot1ersL0%3D 11689847 (Pubitemid 33041886)
5. Q Sun RR Chen Y Shen DJ Mooney S Rajagopalan PM Grossman 2005 Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb Pharm Res 22 1110 1116 10.1007/s11095-005-5644-2 1:CAS:528:DC%2BD2MXmt1yntbo%3D 16028011 (Pubitemid 41127068)
6. X Hao EA Silva A Mansson-Broberg KH Grinnemo AJ Siddiqui G Dellgren, et al. 2007 Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction Cardiovasc Res 75 178 185 10.1016/j.cardiores.2007.03.028 1:CAS:528:DC%2BD2sXmt1yntLw%3D 17481597 (Pubitemid 46876668)
7. DJ Mooney PM Kaufmann K Sano SP Schwendeman K Majahod B Schloo, et al. 1996 Localized delivery of epidermal growth factor improves the survival of transplanted hepatocytes Biotechnol Bioeng 50 422 429 10.1002/(SICI)1097- 0290(19960520)50:4<422::AID-BIT9>3.0.CO;2-N 1:CAS:528:DyaK28XivVyrtbw%3D 18626991 (Pubitemid 26126676)
8. T Couffinhal M Silver M Kearney A Sullivan B Witzenbichler M Magner, et al. 1999 Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice Circulation 99 3188 3198 1:STN:280:DyaK1MzgslSltA%3D%3D 10377084
9. SM Jorgensen O Demirkaya EL Ritman 1998 Three-dimensional imaging of vasculature and parenchyma in intact rodent organs with X-ray micro-CT Am J Physiol 275 H1103 H1114 1:CAS:528:DyaK1cXmtFWjtLg%3D 9724319
10. Q Sun P Yue JA Deiuliis CN Lumeng T Kampfrath MB Mikolaj, et al. 2009 Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity Circulation 119 538 546 10.1161/CIRCULATIONAHA.108.799015 1:CAS:528:DC%2BD1MXpt1ektg%3D%3D 19153269
11. M Simons JA Ware 2003 Therapeutic angiogenesis in cardiovascular disease Nat Rev Drug Discov 2 863 871 10.1038/nrd1226 1:CAS:528:DC%2BD3sXpt1agtbc%3D 14668807
12. S Rajagopalan PM Grossman 2002 Management of chronic critical limb ischemia Cardiol Clin 20 535 545 10.1016/S0733-8651(02)00090-5 12472041 (Pubitemid 35375506)
13. A Helisch W Schaper 2003 Arteriogenesis: the development and growth of collateral arteries Microcirculation 10 83 97 12610665
14. Y Dor V Djonov R Abramovitch A Itin GI Fishman P Carmeliet, et al. 2002 Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy EMBO J 21 1939 1947 10.1093/emboj/21.8.1939 1:CAS:528:DC%2BD38Xjs1Whu78%3D 11953313 (Pubitemid 34437191)
15. R Cao E Brakenhielm R Pawliuk D Wariaro MJ Post E Wahlberg, et al. 2003 Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2 Nat Med 9 604 613 10.1038/nm848 1:CAS:528:DC%2BD3sXjtlamtL4%3D 12669032 (Pubitemid 36597108)
16. SB Freedman JM Isner 2002 Therapeutic angiogenesis for coronary artery disease Ann Intern Med 136 54 71 11777364
17. R Laham 2001 Angiogenesis (clinical trials) Can J Cardiol 17 Suppl A 29A 32A 1:CAS:528:DC%2BD3MXks1SltLw%3D 11381293
18. RK Jain PF Carmeliet 2001 Vessels of death or life Sci Am 285 38 45 10.1038/scientificamerican1201-38 1:STN:280:DC%2BD38%2FjtlCntw%3D%3D 11759584
19. MJ Post R Laham FW Sellke M Simons 2001 Therapeutic angiogenesis in cardiology using protein formulations Cardiovasc Res 49 522 531 10.1016/S0008-6363(00)00216-9 1:CAS:528:DC%2BD3MXptlWrsA%3D%3D 11166265 (Pubitemid 32146415)
20. JD Grossman W Grossman 2002 Angiogenesis Rev Cardiovasc Med 3 138 144 10.1016/S1522-1865(03)00101-X 12439438 (Pubitemid 37329383)
21. MK Nagai JM Embil 2002 Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers Expert Opin Biol Ther 2 211 218 10.1517/14712598.2.2.211 1:CAS:528:DC%2BD38XitVWrtrw%3D 11849120 (Pubitemid 34464823)
22. AB Ennett DJ Mooney 2002 Tissue engineering strategies for in vivo neovascularisation Expert Opin Biol Ther 2 805 818 10.1517/14712598.2.8.805 1:CAS:528:DC%2BD3sXovFCl 12517260 (Pubitemid 36033247)
23. Emerich DF, Mooney DJ, Storrie H, Babu RS, Kordower JH. Injectable hydrogels providing sustained delivery of vascular endothelial growth factor are neuroprotective in a rat model of Huntington's disease. Neurotox Res. 2009. doi: 10.1007/s12640-009-9079-0.
24. DE Discher DJ Mooney PW Zandstra 2009 Growth factors, matrices, and forces combine and control stem cells Science (New York, NY) 324 1673 1677 1:CAS:528:DC%2BD1MXnsFOmtbo%3D
25. G Chan DJ Mooney 2008 New materials for tissue engineering: towards greater control over the biological response Trends Biotechnol 26 382 392 10.1016/j.tibtech.2008.03.011 1:CAS:528:DC%2BD1cXnsF2qtbY%3D 18501452
26. DJ Mooney H Vandenburgh 2008 Cell delivery mechanisms for tissue repair Cell Stem Cell 2 205 213 10.1016/j.stem.2008.02.005 1:CAS:528: DC%2BD1cXjslegsbc%3D 18371446 (Pubitemid 351298597)